UM Submission Instructions: Pathway to Stop Diabetes 2026
| Sponsor: |
American Diabetes Association (ADA) |
| Award Title: |
Pathway to Stop Diabetes |
| Amount: |
$1.625M
Initiator Award: Up to $100,000 USD per year in Phase 1, Up to $325,000 USD per year in Phase 2 Indirect Costs: Up to 10% of direct costs in Phase 1, Up to 30% of direct costs in Phase 2 Award Term: Up to 7 years Accelerator Award: Maximum Requested Budget: $325,000 per year Indirect Costs: Up to 30% Award Term - up to 5 years |
| UM Deadline: |
03/12/2026 |
| Sponsor Deadline: |
05/19/2026 |
| Description: |
Pathway to Stop Diabetes®
Pathway to Stop Diabetes® has a simple, yet revolutionary goal: to find scientists at the peak of their creativity and provide them with the flexibility and resources they need on the road to breakthrough discoveries. We attract and retain brilliant scientists in diabetes.
Our three areas of focus are key components of a unique formula to cultivate the next generation of leaders:
- Awarding research grants
- Providing access to scientific and career mentoring from leading diabetes researchers
- Creating a diabetes think tank
To accelerate the research needed to stop this deadly disease, the American Diabetes Association’s bold transformational initiative is inspiring a new generation of diabetes researchers. Pathway provides crucial support to individuals focusing on innovative ideas and transformational approaches that will lead to ground-breaking discoveries in diabetes prevention, management, and cures. We are building a human pathway to tackle the toughest questions in diabetes by driving research innovations through 1:1 mentorship and the creation of a brain trust in diabetes.
Call for Nominations
This call for nominations will prioritize translational applications that move knowledge and discovery gained from basic research to its eventual translation into patient and population benefit. The ideal applicant will propose innovative research that will be an important step towards the eventual goal of improving the lives of people at risk of diabetes or living with the disease.
ADA will accept up to two (2) nominations per institution:
- One (1) nomination spanning basic through preclinical research
- One (1) nomination spanning clinical through public health research
|
| Number of Applicants University is Allowed to submit: |
2 |
| Additional Requirements: |
None |
| Sponsor Guidelines: |
https://professional.diabetes.org/research-grants/current-funding-opportunities-pathway-stop-diabetes |
| UM Nominations Process: |
Submission Instructions
Those interested in applying should submit the following as a single PDF document to
collabor@umn.edu.
Deadline: no later than 4:00 PM on March 12, 2026
Required Documentation:
-
Cover Page: Must include PI name, department, contact information, project title, and names/departments of any co-PIs.
- Include a one-paragraph project abstract.
- Specify the award type (Initiator or Accelerator).
- Indicate research category: 1) Basic through preclinical, or 2) Clinical through public health.
-
Project Summary: Include solicitation-specific information (not more than three pages).
-
Biosketch of PI: 2–5 pages in NIH format.
-
Reviewer Information:
- 2–3 names of possible UMN reviewers (Note: These are not references and must have no Conflicts of Interest).
- 5 keywords to be used as search terms for potential reviewers (may be added to the Cover Page).
Any questions can be submitted to collabor@umn.edu.
|
| Peer Review Coordination: |
Research and Innovation Office contact email |
| Status: |
Open |
| Please note: |
To be considered for peer review and internal selection, faculty must follow the above submission guidelines and meet the UM deadline as set by the office coordinating the peer review for this opportunity. |
|
|